On November 8^th, 2017, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Fellow in the Field of Pharmaceutical Sciences (Approval Notice).

General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Postdoctoral Research Fellow

Country of Origin: China

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: November 8^th, 2017

Processing Time: 9 days (Premium Processing Requested)

Case Summary:

“It would be detrimental to the field of pharmaceutical science if her work experienced any unnecessary delays, as her efforts are essential for developing superior therapeutic strategies for reducing the cognitive impairments observed in individuals with HIV.”

The statement above was excerpted from a letter of recommendation that was signed by a highly esteemed professor of biochemistry in support of our client’s EB-1A (Alien of Extraordinary Ability) petition. He was joined by five of his peers, all of whom contributed strong recommendation letters supporting the value of our client’s research to the US.

Our client—a postdoctoral research fellow from China— had very strong credentials and she hired our firm to present a convincing EB1A case to the USCIS. She opted for Premium Processing (PP) and received an approval notice just 9 days later. As part of our services, we put together a strong EB-1A petition for her, and these were some of the points we chose to focus on:

• We noted our client’s 5 peer-reviewed scientific articles as well as the 116 citations they had amassed over the years.
• We also detailed her review work made up of 18 peer reviews that she had conducted for high impact journals, proving that she is invaluable to the pharmaceutical sciences research community.
• We also detailed our client’s work on targeted drug discovery for the treatment of HIV infection and inflammatory diseases. Based on what we learned from our client’s research summary, we persuaded the USCIS that her research addresses some of the United States’ most pressing issues in understanding the effects of methamphetamine abuse and HIV infection on the production of inflammatory cytokines in macrophages.

We are extremely pleased that our client’s EB-1A petition was approved by the USCIS, and we thank her for working with us. We wish her the best as she embarks on the second and final step of the green card journey: filing an I-485 application, which she is doing with the help of our DIY packet.